Advertisement

Smoking cessation Through Optimization of clinical care in Pregnancy: the STOP pragmatic randomized controlled trial

Published:October 07, 2022DOI:https://doi.org/10.1016/j.ajogmf.2022.100763

      BACKGROUND

      Smoking cessation improves pregnancy outcomes, yet there is uncertainty around the efficacy of models of antenatal intervention for smoking cessation in pregnancy.

      OBJECTIVE

      This study aimed to test the Smoking cessation Through Optimization of clinical care in Pregnancy (STOP) clinic as an antenatal care pathway for smoking cessation in pregnancy. The STOP intervention is a smoking cessation clinic staffed by a dedicated multidisciplinary team of obstetricians, midwives, and smoking cessation practitioners, who provide motivational and psychological support and intensive clinical monitoring of pregnancy.

      STUDY DESIGN

      This was a pragmatic randomized controlled trial of the STOP clinic compared with routine antenatal care at a tertiary urban maternity hospital delivering >8000 infants per year. The primary outcome measured was continuous abstinence from smoking before 28+0 weeks’ gestation, sustained throughout the duration of the pregnancy, and validated using biological measures. The secondary outcomes included maternal and fetal morbidity, delivery and neonatal outcomes, smoking outcomes, and qualitative measures.

      RESULTS

      A total of 436 women were randomized, with 430 women included in the primary outcome analysis. Women attending the STOP antenatal clinic were more likely to quit smoking compared with those in routine care (odds ratio, 3.62; 95% confidence interval, 1.43–9.17). In addition, women who continued to smoke in the STOP clinic smoked fewer cigarettes daily at the time of delivery compared with controls: 5±4 in the STOP clinic and 7±5 in the control group (odds ratio, 0.28; 95% confidence interval, 0.13–0.59). However, this intervention did not alter postpartum relapse rates (4.3% intervention arm vs 1.5% control arm, not significant) at 4 to 6 months following delivery. The mean birthweight was similar in the intervention and control arms; however, quitters in both groups had infants with significantly higher birthweights compared with those of continued smokers.

      CONCLUSION

      The STOP antenatal model of care leads to higher smoking cessation rates among pregnant smokers and lower daily cigarette consumption at time of delivery. Currently, there is no defined or dedicated antenatal pathway for pregnant smokers, despite the high-risk nature of their pregnancies. Our findings suggest that improved smoking cessation rates in pregnancy may be achieved using the holistic approach of the STOP model of care.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cnattingius S.
        The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes.
        Nicotine Tob Res. 2004; 6: S125-S140
        • Marufu TC
        • Ahankari A
        • Coleman T
        • Lewis S.
        Maternal smoking and the risk of still birth: systematic review and meta-analysis.
        BMC Public Health. 2015; 15: 239
      1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics and the Society for Maternal-Fetal Medicine. ACOG Practice Bulletin No. 204: fetal growth restriction.
        Obstet Gynecol. 2019; 133: e97-109
        • Crowther CA
        • Hiller JE
        • Moss JR
        • et al.
        Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.
        N Engl J Med. 2005; 352: 2477-2486
      2. Chamberlain C, O'Mara-Eves A, Porter J, Coleman T, Perlen SM, Thomas J, McKenzie JE. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD001055. https://doi.org/10.1002/14651858.CD001055.pub5.

        • Claire R
        • Chamberlain C
        • Davey MA
        • et al.
        Pharmacological interventions for promoting smoking cessation during pregnancy.
        Cochrane Database Syst Rev. 2020; 3CD010078
        • Ohakim A
        • Mellon L
        • Jafar B
        • et al.
        Smoking, attitudes to smoking and provision of smoking cessation advice in two teaching hospitals in Ireland: do smoke-free policies matter?.
        Heal Psychol Behav Med. 2015; 3: 142-153
        • Michie S
        • van Stralen MM
        • West R.
        The behaviour change wheel: a new method for characterising and designing behaviour change interventions.
        Implement Sci. 2011; 6: 42
        • Ussher M
        • Aveyard P
        • Manyonda I
        • et al.
        Physical activity as an aid to smoking cessation during pregnancy (LEAP) trial: study protocol for a randomized controlled trial.
        Trials. 2012; 13: 186
        • Cooper S
        • Orton S
        • Leonardi-Bee J
        • et al.
        Smoking and quit attempts during pregnancy and postpartum: a longitudinal UK cohort.
        BMJ Open. 2017; 7e018746
      3. StataCorp. Stata statistical software. Release 16. College Station, TX: StataCorp LLC; 2019.

        • McDonnell BP
        • Dicker P
        • Keogan S
        • Clancy L
        • Regan C.
        Smoking cessation through optimisation of clinical care in pregnancy: the STOP randomised controlled trial.
        Trials. 2019; 20: 550
      4. NCSCT Training Standard. Third Edition, 2018. Editors: Sophia Papadakis and Andy McEwen. Published by National Centre for Smoking Cessation and Training. Available from: https://www.ncsct.co.uk/usr/pub/NCSCT_training_standard.pdf.

        • West R
        • Hajek P
        • Stead L
        • Stapleton J.
        Outcome criteria in smoking cessation trials: proposal for a common standard.
        Addiction. 2005; 100: 299-303
        • McDonnell BP
        • Keogan S
        • Clancy L
        • Regan C.
        Smoking cessation support and obstetric outcomes in an Irish maternity hospital.
        Eur J Obstet Gynecol Reprod Biol. 2019; 232: 1-4
        • Reynolds CME
        • Egan B
        • Cawley S
        • Kennedy R
        • Sheehan SR
        • Turner MJ.
        A national audit of smoking cessation services in Irish maternity units.
        Ir Med J. 2017; 110: 580
        • Coleman T
        • Cooper S
        • Thornton JG
        • et al.
        A randomized trial of nicotine-replacement therapy patches in pregnancy.
        N Engl J Med. 2012; 366: 808-818
        • Berlin I
        • Grangé G
        • Jacob N
        • Tanguy ML.
        Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy.
        BMJ. 2014; 348: g1622
        • Wisborg K
        • Henriksen TB
        • Jespersen LB
        • Secher NJ.
        Nicotine patches for pregnant smokers: a randomized controlled study.
        Obstet Gynecol. 2000; 96: 967-971
        • Kapur B
        • Hackman R
        • Selby P
        • Klein J
        • Koren G.
        Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy.
        Curr Ther Res Clin Exp. 2001; 62: 274-278
        • Pollak KI
        • Oncken CA
        • Lipkus IM
        • et al.
        Nicotine replacement and behavioral therapy for smoking cessation in pregnancy.
        Am J Prev Med. 2007; 33: 297-305
        • El-Mohandes AAE
        • Windsor R
        • Tan S
        • Perry DC
        • Gantz MG
        • Kiely M.
        A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers.
        Matern Child Health J. 2013; 17: 897-906
        • Hotham ED
        • Gilbert AL
        • Atkinson ER.
        A randomised-controlled pilot study using nicotine patches with pregnant women.
        Addict Behav. 2006; 31: 641-648
        • Lindmark G
        • Cnattingius S.
        The scientific basis of antenatal care. Report from a state-of-the-art conference.
        Acta Obstet Gynecol Scand. 1991; 70: 105-109
        • BergsjØ P
        • Villar J
        Scientific basis for the content of routine antenatal care. II. Power to eliminate or alleviate adverse newborn outcomes; some special conditions and examinations.
        Acta Obstet Gynecol Scand. 1997; 76: 15-25
        • Fang WL
        • Goldstein AO
        • Butzen AY
        • et al.
        Smoking cessation in pregnancy: a review of postpartum relapse prevention strategies.
        J Am Board Fam Pract. 2004; 17: 264-275
        • Fitzpatrick KE
        • Gray R
        • Quigley MA.
        Women's longitudinal patterns of smoking during the pre-conception, pregnancy and postnatal period: evidence from the UK infant feeding survey.
        PLoS One. 2016; 11e0153447
        • Solomon LJ
        • Higgins ST
        • Heil SH
        • Badger GJ
        • Thomas CS
        • Bernstein IM.
        Predictors of postpartum relapse to smoking.
        Drug Alcohol Depend. 2007; 90: 224-227
        • Harmer C
        • Memon A.
        Factors associated with smoking relapse in the postpartum period: an analysis of the child health surveillance system data in Southeast England.
        Nicotine Tob Res. 2013; 15: 904-909
        • Singleterry J
        • Jump Z
        • DiGiulio A
        • et al.
        State Medicaid coverage for tobacco cessation treatments and barriers to coverage - United States, 2014-2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1194-1199
        • Scherman A
        • Tolosa JE
        • McEvoy C.
        Smoking cessation in pregnancy: a continuing challenge in the United States.
        Ther Adv Drug Saf. 2018; 9: 457-474
        • Lightwood JM
        • Phibbs CS
        • Glantz SA.
        Short-term health and economic benefits of smoking cessation: low birth weight.
        Pediatrics. 1999; 104: 1312-1320
        • Jones M
        • Smith M
        • Lewis S
        • Parrott S
        • Coleman T.
        A dynamic, modifiable model for estimating cost-effectiveness of smoking cessation interventions in pregnancy: application to an RCT of self-help delivered by text message.
        Addiction. 2019; 114: 353-365
        • Vardavas CI
        • Chatzi L
        • Patelarou E
        • et al.
        Smoking and smoking cessation during early pregnancy and its effect on adverse pregnancy outcomes and fetal growth.
        Eur J Pediatr. 2010; 169: 741-748
        • SRNT Subcommittee on Biochemical Verification
        Biochemical verification of tobacco use and cessation.
        Nicotine Tob Res. 2002; 4: 149-159
        • Thompson TP
        • Greaves CJ
        • Ayres R
        • et al.
        Factors associated with study attrition in a pilot randomised controlled trial to explore the role of exercise-assisted reduction to stop (EARS) smoking in disadvantaged groups.
        Trials. 2016; 17: 524
        • Ussher M
        • Lewis S
        • Aveyard P
        • et al.
        The London exercise and pregnant smokers (LEAP) trial: a randomised controlled trial of physical activity for smoking cessation in pregnancy with an economic evaluation.
        Health Technol Assess. 2015; 19: 1-135
        • Reynolds CME
        • Egan B
        • O'Malley EG
        • Kennedy RRA
        • Sheehan SR
        • Turner MJ
        Feasibility of recruitment to a behavioural smoking cessation intervention combined with ongoing online support.
        Eur J Public Health. 2019; 29: 170-172